Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol. [electronic resource]
- Anticancer research
- 4011-8 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0250-7005
Adenocarcinoma--drug therapy Animals Antineoplastic Agents, Phytogenic--therapeutic use Breast Neoplasms--drug therapy Combined Modality Therapy Female Heterocyclic Compounds--pharmacokinetics Humans Mice Mice, Nude Oligopeptides--pharmacokinetics Paclitaxel--therapeutic use Radioimmunotherapy Time Factors Transplantation, Heterologous Tumor Cells, Cultured Yttrium--pharmacokinetics